B-cell lymphoma is a type of cancer that typically develops in the lymphatic system. It accounts for approximately 85 percent ...

Volrustomig is under clinical development by AstraZeneca and currently in Phase II for Malignant Neoplasms. According to GlobalData, Phase II drugs for Malignant Neoplasms does not have sufficient ...

Myeloproliferative neoplasms are blood cancers that affect myeloid stem cells. Treatment can involve targeted medications or careful monitoring. Myeloproliferative disorders are a group of cancers ...

IN previous publications some kinetic investigations concerning the optimal physico-chemical conditions of incorporation of heterologous and homologous DNA into Novikoff hepatoma cells and Ehrlich ...

gDepartment of Pathology and Stanford Center for Genomics and Personalized Medicine, Stanford University School of Medicine, Stanford, CA, USA, hStanford Cancer Institute, Stanford University School ...